Domingo: FDA Yet To Start Evaluation Of Sinopharm’s Application For EUA
The FDA had yet to start the evaluation of Sinopharm’s application for EUA, according to Domingo. FDA Director-General Eric Domingo on Wednesday said that the country’s Food and Drug Administration was yet to start its evaluation of China’s Sinopharm’s application for emergency use authorization (EUA) of its COVID-19 vaccine. In a report on GMA News … Read more
